Caxton Associates (New York)’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-134,047	Closed	-$2.77M	–	390
2018 Q4	$2.77M	Buy	134,047 +30,000	+29%	+$620K	0.44%	24
2018 Q3	$2.26M	Buy	+104,047	New	+$2.26M	0.16%	81